Dexmedetomidine intranasal - Jiangsu HengRui Medicine Co.
Latest Information Update: 05 Oct 2017
Price : *
At a glance
- Originator Jiangsu Hengrui Medicine Co.
- Class Anxiolytics; Hypnosedatives; Imidazoles; Non-opioid analgesics; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Sedation
Most Recent Events
- 26 Jul 2017 Phase-I clinical trials in Sedation (In volunteers) in China (Intranasal) (NCT03293277)